1.1500
05-11月-24 15:59:03
15 分の遅延
株式
-0.0200
-1.71%
本日の幅
1.1401 - 1.1900
ISIN
N/A
ソース
NASDAQ
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
23 10 2024 08:00:01 提供 Nasdaq GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
22 10 2024 08:00:01 提供 Nasdaq GlobeNewswire
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
15 10 2024 08:00:00 提供 Nasdaq GlobeNewswire